GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SGX:T14) » Definitions » Cyclically Adjusted PS Ratio

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Cyclically Adjusted PS Ratio : 3.64 (As of Jun. 05, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PS Ratio?

As of today (2024-06-05), Tianjin Pharmaceutical Da Ren Tang Group's current share price is $2.55. Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $0.70. Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio for today is 3.64.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

SGX:T14' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.42   Med: 2.61   Max: 5.72
Current: 3.61

During the past years, Tianjin Pharmaceutical Da Ren Tang Group's highest Cyclically Adjusted PS Ratio was 5.72. The lowest was 1.42. And the median was 2.61.

SGX:T14's Cyclically Adjusted PS Ratio is ranked worse than
72.08% of 745 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs SGX:T14: 3.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tianjin Pharmaceutical Da Ren Tang Group's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.374. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PS Ratio Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.60 1.96 3.40 3.03 3.47

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.18 4.68 3.77 3.47 2.86

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio falls into.



Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2.55/0.7
=3.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tianjin Pharmaceutical Da Ren Tang Group's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.374/115.2271*115.2271
=0.374

Current CPI (Mar. 2024) = 115.2271.

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.388 98.200 0.455
201409 0.390 98.900 0.454
201412 0.414 99.000 0.482
201503 0.348 99.900 0.401
201506 0.376 99.500 0.435
201509 0.353 100.500 0.405
201512 0.411 100.600 0.471
201603 0.330 102.200 0.372
201606 0.321 101.400 0.365
201609 0.297 102.400 0.334
201612 0.264 102.600 0.296
201703 0.273 103.200 0.305
201706 0.293 103.100 0.327
201709 0.267 104.100 0.296
201712 0.273 104.500 0.301
201803 0.339 105.300 0.371
201806 0.296 104.900 0.325
201809 0.297 106.600 0.321
201812 0.315 106.500 0.341
201903 0.340 107.700 0.364
201906 0.334 107.700 0.357
201909 0.306 109.800 0.321
201912 0.329 111.200 0.341
202003 0.305 112.300 0.313
202006 0.301 110.400 0.314
202009 0.319 111.700 0.329
202012 0.327 111.500 0.338
202103 0.369 112.662 0.377
202106 0.361 111.769 0.372
202109 0.346 112.215 0.355
202112 0.318 113.108 0.324
202203 0.388 114.335 0.391
202206 0.366 114.558 0.368
202209 0.323 115.339 0.323
202212 0.495 115.116 0.495
202303 0.406 115.116 0.406
202306 0.352 114.558 0.354
202309 0.299 115.339 0.299
202312 0.445 114.781 0.447
202403 0.374 115.227 0.374

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tianjin Pharmaceutical Da Ren Tang Group  (SGX:T14) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Tianjin Pharmaceutical Da Ren Tang Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Headlines

No Headlines